BBC Global Women reports on a social media trend of taking weight-loss injections at far lower doses than prescribed.
Recap by typeshit. Post by @bbcglobalwomen on Instagram.
Dr. Hamrah points out that 'peptide' covers everything from insulin to GLP-1s, and says the label alone tells you nothing about safety or evidence.
Ennis says no one asked about her surgical history or anemia before she began, and she later needed a transfusion. She lists questions clinicians should ask.
19:37
Dermatologist Dr Dray looks at the safety of popular injectable peptides like BPC-157 and TB-500 that are marketed for anti-aging.
A patient stopped Wegovy for weeks around surgery and asks others whether symptoms returned when they came off it.
She separates FDA-approved drugs from animal-only and internet-hype compounds, from BPC-157 and Epitalon to retatrutide, and stresses that mechanism isn't proof.
TIKR points to retatrutide, due for filing in early 2027, and says a pending Seventh Circuit ruling on whether it counts as a biologic could decide 5 vs 12 years of exclusivity.
Loading…